Cargando…

MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma

Cluster of differentiation 147 (CD147/BSG) is a transmembrane glycoprotein mediating oncogenic processes partly through its role as binding partner for monocarboxylate transporter MCT4/SLC16A3. As demonstrated for MCT4, CD147 is proposed to be associated with progression in clear cell renal cell car...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisel, Pascale, Stühler, Viktoria, Bedke, Jens, Winter, Stefan, Rausch, Steffen, Hennenlotter, Jörg, Nies, Anne T., Stenzl, Arnulf, Scharpf, Marcus, Fend, Falko, Kruck, Stephan, Schwab, Matthias, Schaeffeler, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741556/
https://www.ncbi.nlm.nih.gov/pubmed/26384346
_version_ 1782414017682210816
author Fisel, Pascale
Stühler, Viktoria
Bedke, Jens
Winter, Stefan
Rausch, Steffen
Hennenlotter, Jörg
Nies, Anne T.
Stenzl, Arnulf
Scharpf, Marcus
Fend, Falko
Kruck, Stephan
Schwab, Matthias
Schaeffeler, Elke
author_facet Fisel, Pascale
Stühler, Viktoria
Bedke, Jens
Winter, Stefan
Rausch, Steffen
Hennenlotter, Jörg
Nies, Anne T.
Stenzl, Arnulf
Scharpf, Marcus
Fend, Falko
Kruck, Stephan
Schwab, Matthias
Schaeffeler, Elke
author_sort Fisel, Pascale
collection PubMed
description Cluster of differentiation 147 (CD147/BSG) is a transmembrane glycoprotein mediating oncogenic processes partly through its role as binding partner for monocarboxylate transporter MCT4/SLC16A3. As demonstrated for MCT4, CD147 is proposed to be associated with progression in clear cell renal cell carcinoma (ccRCC). In this study, we evaluated the prognostic relevance of CD147 in comparison to MCT4/SLC16A3 expression and DNA methylation. METHODS: CD147 protein expression was assessed in two independent ccRCC-cohorts (n = 186, n = 59) by immunohistochemical staining of tissue microarrays and subsequent manual as well as automated software-supported scoring (Tissue Studio, Definien sAG). Epigenetic regulation of CD147 was investigated using RNAseq and DNA methylation data of The Cancer Genome Atlas. These results were validated in our cohort. Relevance of prognostic models for cancer-specific survival, comprising CD147 and MCT4 expression or SLC16A3 DNA methylation, was compared using chi-square statistics. RESULTS: CD147 protein expression generated with Tissue Studio correlated significantly with those from manual scoring (P < 0.0001, r(S) = 0.85), indicating feasibility of software-based evaluation exemplarily for the membrane protein CD147 in ccRCC. Association of CD147 expression with patient outcome differed between cohorts. DNA methylation in the CD147/BSG promoter was not associated with expression. Comparison of prognostic relevance of CD147/BSG and MCT4/SLC16A3, showed higher significance for MCT4 expression and superior prognostic power for DNA methylation at specific CpG-sites in the SLC16A3 promoter (e.g. CD147 protein: P = 0.7780, Harrell's c-index = 53.7% vs. DNA methylation: P = 0.0076, Harrell's c-index = 80.0%). CONCLUSIONS: Prognostic significance of CD147 protein expression could not surpass that of MCT4, especially of SLC16A3 DNA methylation, corroborating the role of MCT4 as prognostic biomarker for ccRCC.
format Online
Article
Text
id pubmed-4741556
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47415562016-03-03 MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma Fisel, Pascale Stühler, Viktoria Bedke, Jens Winter, Stefan Rausch, Steffen Hennenlotter, Jörg Nies, Anne T. Stenzl, Arnulf Scharpf, Marcus Fend, Falko Kruck, Stephan Schwab, Matthias Schaeffeler, Elke Oncotarget Research Paper: Pathology Cluster of differentiation 147 (CD147/BSG) is a transmembrane glycoprotein mediating oncogenic processes partly through its role as binding partner for monocarboxylate transporter MCT4/SLC16A3. As demonstrated for MCT4, CD147 is proposed to be associated with progression in clear cell renal cell carcinoma (ccRCC). In this study, we evaluated the prognostic relevance of CD147 in comparison to MCT4/SLC16A3 expression and DNA methylation. METHODS: CD147 protein expression was assessed in two independent ccRCC-cohorts (n = 186, n = 59) by immunohistochemical staining of tissue microarrays and subsequent manual as well as automated software-supported scoring (Tissue Studio, Definien sAG). Epigenetic regulation of CD147 was investigated using RNAseq and DNA methylation data of The Cancer Genome Atlas. These results were validated in our cohort. Relevance of prognostic models for cancer-specific survival, comprising CD147 and MCT4 expression or SLC16A3 DNA methylation, was compared using chi-square statistics. RESULTS: CD147 protein expression generated with Tissue Studio correlated significantly with those from manual scoring (P < 0.0001, r(S) = 0.85), indicating feasibility of software-based evaluation exemplarily for the membrane protein CD147 in ccRCC. Association of CD147 expression with patient outcome differed between cohorts. DNA methylation in the CD147/BSG promoter was not associated with expression. Comparison of prognostic relevance of CD147/BSG and MCT4/SLC16A3, showed higher significance for MCT4 expression and superior prognostic power for DNA methylation at specific CpG-sites in the SLC16A3 promoter (e.g. CD147 protein: P = 0.7780, Harrell's c-index = 53.7% vs. DNA methylation: P = 0.0076, Harrell's c-index = 80.0%). CONCLUSIONS: Prognostic significance of CD147 protein expression could not surpass that of MCT4, especially of SLC16A3 DNA methylation, corroborating the role of MCT4 as prognostic biomarker for ccRCC. Impact Journals LLC 2015-09-10 /pmc/articles/PMC4741556/ /pubmed/26384346 Text en Copyright: © 2015 Fisel et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Pathology
Fisel, Pascale
Stühler, Viktoria
Bedke, Jens
Winter, Stefan
Rausch, Steffen
Hennenlotter, Jörg
Nies, Anne T.
Stenzl, Arnulf
Scharpf, Marcus
Fend, Falko
Kruck, Stephan
Schwab, Matthias
Schaeffeler, Elke
MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title_full MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title_fullStr MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title_full_unstemmed MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title_short MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma
title_sort mct4 surpasses the prognostic relevance of the ancillary protein cd147 in clear cell renal cell carcinoma
topic Research Paper: Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741556/
https://www.ncbi.nlm.nih.gov/pubmed/26384346
work_keys_str_mv AT fiselpascale mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT stuhlerviktoria mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT bedkejens mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT winterstefan mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT rauschsteffen mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT hennenlotterjorg mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT niesannet mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT stenzlarnulf mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT scharpfmarcus mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT fendfalko mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT kruckstephan mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT schwabmatthias mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma
AT schaeffelerelke mct4surpassestheprognosticrelevanceoftheancillaryproteincd147inclearcellrenalcellcarcinoma